Stocktoria
FITLIFE BRANDS, INC. FTLF
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2007-10-26
FITLIFE BRANDS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $15.9M | $64.5M | $52.7M | $28.8M | $27.9M |
| Gross profit | $6.9M | $28.1M | $21.4M | $12.0M | $12.5M |
| SG&A expense | $2.5M | $10.0M | $7.9M | $6.0M | $6.2M |
| Operating income | $3.0M | $13.1M | $7.5M | $5.7M | $6.2M |
| Interest expense | — | — | $1.0M | $0 | — |
| Income tax | $701,000 | $2.9M | $1.7M | $1.4M | $1.3M |
| Net income | $2.0M | $9.0M | $5.3M | $4.4M | $5.4M |
| EPS (diluted) | $0.20 | $0.91 | $0.54 | $0.89 | $1.13 |
| Operating cash flow | $7.4M | $9.6M | $4.2M | $4.1M | $4.5M |
| Free cash flow | $7.4M | $9.6M | $4.1M | $4.1M | — |
| Inventory | $21.3M | $11.1M | $9.1M | $9.1M | $6.5M |
| Total assets | $106.3M | $58.5M | $55.3M | $25.7M | $21.5M |
| Total liabilities | $62.7M | $22.4M | $28.3M | $4.3M | $4.2M |
| Shareholders' equity | $43.6M | $36.1M | $27.0M | $21.4M | $17.3M |
Source: SEC EDGAR filings · CIK 0001374328 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.